Multifocal ERG and Microperimetry Changes in Response to Ranibizumab Treatment of Neovascular AMD: Randomized Phase 2 Open-Label Study

PURPOSE: To compare monthly versus pro re nata (PRN) ranibizumab injections in the treatment of exudative macular degeneration (AMD) while assessing the utility of microperimetry (MP) and multifocal electroretinography (mfERG) testing when monitoring response to treatment. METHODS: A randomized expl...

Descripción completa

Detalles Bibliográficos
Autores principales: Asahi, Masumi G, Wallsh, Josh, Onishi, Spencer M, Kuroyama, Shari, Gallemore, Ron P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605973/
https://www.ncbi.nlm.nih.gov/pubmed/33154619
http://dx.doi.org/10.2147/OPTH.S270243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605973/
https://www.ncbi.nlm.nih.gov/pubmed/33154619
http://dx.doi.org/10.2147/OPTH.S270243

Ejemplares similares